Pattern Bioscience is addressing the critical global challenge of antibiotic resistance through advanced diagnostic technology. The company develops rapid identification and antimicrobial susceptibility testing (ID/AST) assays directly from clinical specimens, utilizing a proprietary platform to deliver timely and accurate results. This innovative approach allows healthcare providers to quickly determine the most effective antibiotics for treating bacterial infections, ultimately improving patient outcomes. Pattern Bioscience fosters a culture of collaboration and continuous learning, emphasizing diversity and inclusion within its multidisciplinary team. The organization is dedicated to making a significant public health impact and seeks individuals who are passionate about microbiology and eager to contribute to solutions in the fight against antibiotic resistance.